P. D. de Blank

发表

American Brain Tumor Association Adolescent and Young Adult Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2008-2012.

J. Barnholtz-Sloan, Q. Ostrom, Yingli Wolinsky, 2016, Neuro-oncology.

Trends in Clostridium difficile infection and risk factors for hospital acquisition of Clostridium difficile among children with cancer.

A. Troxel, P. de Blank, T. Zaoutis, 2013, The Journal of pediatrics.

Recommendations for Social Skills End Points for Clinical Trials in Neurofibromatosis Type 1

K. Walsh, P. de Blank, N. Ullrich, 2021, Neurology.

Subsequent Neoplasms After a Primary Tumor in Individuals With Neurofibromatosis Type 1.

B. Korf, G. Armstrong, L. Robison, 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Response assessment in paediatric low-grade glioma: recommendations from the Response Assessment in Pediatric Neuro-Oncology (RAPNO) working group.

K. Yeom, M. J. van den Bent, A. Brandes, 2020, The Lancet. Oncology.

Characterizing temporal genomic heterogeneity in pediatric low-grade gliomas

A. Asher, P. de Blank, J. Finlay, 2020, Acta Neuropathologica Communications.

A new era for myelin research in Neurofibromatosis type 1

P. de Blank, A. Nishiyama, A. López-Juárez, 2023, Glia.

Late Morbidity and Mortality in Adult Survivors of Childhood Glioma with Neurofibromatosis Type 1: Report from the Childhood Cancer Survivor Study

G. Armstrong, K. Krull, L. Robison, 2020, Genetics in Medicine.

Late morbidity and mortality in adult survivors of childhood glioma with neurofibromatosis type 1: report from the Childhood Cancer Survivor Study

G. Armstrong, K. Krull, L. Robison, 2020, Genetics in Medicine.

Fractional anisotropy of the optic radiations is associated with visual acuity loss in optic pathway gliomas of neurofibromatosis type 1.

J. Berman, P. de Blank, T. Roberts, 2013, Neuro-oncology.

Optic Pathway Gliomas in Neurofibromatosis Type 1: An Update: Surveillance, Treatment Indications, and Biomarkers of Vision.

D. Gutmann, P. de Blank, R. Ferner, 2017, Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society.

Advanced Magnetic Resonance Imaging in Optic Pathway Gliomas

P. de Blank, S. Ellika, Michael J. Fisher, 2015, Journal of Pediatric Neuroradiology.

Trametinib-associated Hyponatremia in a Child With Low-grade Glioma is Not Seen Following Treatment With Alternative MEK Inhibitor.

P. de Blank, M. Fouladi, R. Salloum, 2020, Journal of pediatric hematology/oncology.

Shedding New Light: Novel Therapies for Common Disorders in Children with Neurofibromatosis Type I.

Natasha Pillay-Smiley, Jonathan S. Fletcher, Natasha Pillay-Smiley, 2023, Pediatric clinics of North America.

Alex's Lemonade Stand Foundation Infant and Childhood Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2007-2011.

Jill S Barnholtz-Sloan, Peter Liao, J. Barnholtz-Sloan, 2015, Neuro-oncology.

Evaluating Focal Areas of Signal Intensity (FASI) in Children with Neurofibromatosis Type-1 (NF1) Treated with Selumetinib on Pediatric Brain Tumor Consortium (PBTC)-029B

P. de Blank, J. Fangusaro, A. Lane, 2023, Cancers.

Risk Factors for Treatment Refractory and Relapsed Optic Pathway Glioma in Children with Neurofibromatosis Type 1.

Michael Fisher, D. Gutmann, P. de Blank, 2022, Neuro-oncology.

Molecular markers and targeted therapy in pediatric low-grade glioma

J. Huse, P. de Blank, M. Fouladi, 2020, Journal of Neuro-Oncology.

Management of pediatric low-grade glioma

P. de Blank, J. Fangusaro, D. Haas-Kogan, 2019, Current opinion in pediatrics.

A Radiomic Approach for Evaluating Intra-Subgroup Heterogeneity in SHH and Group 4 Pediatric Medulloblastoma: A Preliminary Multi-Institutional Study

P. D. de Blank, Marwa Ismail, H. Um, 2024, Cancers.

Years of life lived with disease and years of potential life lost in children who die of cancer in the United States, 2009

J. Barnholtz-Sloan, Q. Ostrom, Yingli Wolinsky, 2015, Cancer medicine.

Opportunities and Advances in Radiomics and Radiogenomics for Pediatric Medulloblastoma Tumors

P. Tiwari, Raheel Ahmed, Marwa Ismail, 2023, Diagnostics.

Incidence and survival trends for medulloblastomas in the United States from 2001 to 2013

J. Barnholtz-Sloan, Q. Ostrom, P. de Blank, 2017, Journal of Neuro-Oncology.

A phase I/II study of ribociclib following radiation therapy in children with newly diagnosed diffuse intrinsic pontine glioma (DIPG)

D. Witte, P. de Blank, C. Fuller, 2020, Journal of Neuro-Oncology.

Human fetal cerebellar cell atlas informs medulloblastoma origin and oncogenesis

Xinran Dong, Feng Yue, Yaping Liu, 2022, bioRxiv.

Recommendations for Measurement of Attention Outcomes in Preschoolers With Neurofibromatosis

K. Walsh, P. de Blank, J. Payne, 2021, Neurology.

Novel MRI deformation-heterogeneity radiomic features are associated with molecular subgroups and overall survival in pediatric medulloblastoma: Preliminary findings from a multi-institutional study

A. Madabhushi, P. de Blank, A. Judkins, 2022, Frontiers in Oncology.

MEK Inhibitors for Neurofibromatosis Type 1 Manifestations: Clinical Evidence and Consensus.

M. Loh, Michael Fisher, K. Walsh, 2022, Neuro-oncology.

Neurocognitive outcomes in neurofibromatosis clinical trials

K. Walsh, P. de Blank, S. Solomon, 2016, Neurology.